SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED

Other languages Shandong Xinhua Pharmaceutical Company Limited

Equities

719 CNE100000411

Market Closed - Hong Kong S.E. Other stock markets 04:09:00 2024-05-03 am EDT			5-day change	1st Jan Change
5.44 ^HKD	-1.45%		-0.18%	-5.88%

Apr. 25	Shandong Xinhua Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 11	Xinhua Pharma Unit's Cefaclor Capsules Passes Regulatory Evaluation	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Shandong Xinhua Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25
Xinhua Pharma Unit's Cefaclor Capsules Passes Regulatory Evaluation	Apr. 11
Shandong Xinhua Pharmaceutical Company Limited Receives Notification of Approval of Supplementary Drug Application	Apr. 08
Shandong Xinhua Pharmaceutical Posts Higher 2023 Profit	Mar. 29
Shandong Xinhua Pharmaceutical Proposes New Auditor	Mar. 28
Shandong Xinhua Pharmaceutical Company Limited Proposes Final Dividend for the Year Ended 31 December 2023	Mar. 28
Shandong Xinhua Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28
Xinhua Pharma's Ibuprofen Gets Registration Approval in China	Mar. 13
Shandong Xinhua Pharmaceutical Company Limited Receives Notification of Approval of Application for Marketing of Active Pharmaceutical Ingredient	Feb. 28
Shandong Xinhua Pharmaceutical Company Limited Announces on Memantine Hydrochloride Tablets Obtaining the Drug Registration Certificate	Jan. 19
Shandong Xinhua Pharmaceutical Company Limited Announces Executive Changes	Dec. 25
Shandong Xinhua Pharmaceutical Gets Certificate for Registration of Levamlodiping Besylate Tablets	Dec. 13
Shandong Xinhua Pharmaceutical Company Limited Receives Drug Registration Certificate of levamlodiping besylate tablets (2.5mg)	Dec. 13
Respiratory Drug by Xinhua Pharmaceutical Unit Passes Regulatory Evaluation for Generic Drugs in China	Dec. 04
Xinhua Pharmaceutical's Nine-Month Profit Jumps 34%	23-10-30
Shandong Xinhua Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27
Shandong Xinhua Pharmaceutical’s AntiCoagulant Tablets Get Drug Registration Certificate	23-10-18
China Grants Marketing Approval for Shandong Xinhua Pharmaceutical's Uric Acid Medication; Shares Rise 4%	23-10-11
Shandong Xinhua Pharmaceutical Company Limited Announces Approval of Marketing Application for Chemical Raw Material Drugs for Drugsof Febuxostat	23-10-10
Xinhua Pharmaceutical Unit's Clarithromycin Granules Passes Regulatory Evaluation	23-09-20

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Shandong Xinhua Pharmaceutical Company Limited

Equities

719

CNE100000411

Other languages

Filters